Annual Working Capital
$2.07 M
-$10.63 M-83.71%
31 December 2023
Summary:
Oragenics annual working capital is currently $2.07 million, with the most recent change of -$10.63 million (-83.71%) on 31 December 2023. During the last 3 years, it has fallen by -$24.19 million (-92.13%). OGEN annual working capital is now -92.13% below its all-time high of $26.26 million, reached on 31 December 2021.OGEN Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$1.99 M
+$1.75 M+742.94%
30 September 2024
Summary:
Oragenics quarterly working capital is currently $1.99 million, with the most recent change of +$1.75 million (+742.94%) on 30 September 2024. Over the past year, it has dropped by -$80.80 thousand (-3.91%). OGEN quarterly working capital is now -94.46% below its all-time high of $35.85 million, reached on 31 March 2021.OGEN Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
OGEN Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -3.9% |
| 3 y3 years | -92.1% | -92.4% |
| 5 y5 years | -87.8% | -88.3% |
OGEN Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -92.1% | at low | -92.4% | +742.9% |
| 5 y | 5 years | -92.1% | at low | -94.5% | +742.9% |
| alltime | all time | -92.1% | +124.8% | -94.5% | +123.9% |
Oragenics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.99 M(+742.9%) |
| June 2024 | - | $235.70 K(-84.6%) |
| Mar 2024 | - | $1.53 M(-25.8%) |
| Dec 2023 | $2.07 M(-83.7%) | $2.07 M(-67.8%) |
| Sept 2023 | - | $6.41 M(-7.8%) |
| June 2023 | - | $6.96 M(-29.9%) |
| Mar 2023 | - | $9.92 M(-21.8%) |
| Dec 2022 | $12.69 M(-51.7%) | $12.69 M(-2.5%) |
| Sept 2022 | - | $13.02 M(-21.2%) |
| June 2022 | - | $16.51 M(-18.4%) |
| Mar 2022 | - | $20.24 M(-22.9%) |
| Dec 2021 | $26.26 M(+57.8%) | $26.26 M(-7.3%) |
| Sept 2021 | - | $28.34 M(-12.9%) |
| June 2021 | - | $32.55 M(-9.2%) |
| Mar 2021 | - | $35.85 M(+115.5%) |
| Dec 2020 | $16.64 M(-2.0%) | $16.64 M(+76.5%) |
| Sept 2020 | - | $9.43 M(+10.1%) |
| June 2020 | - | $8.56 M(-32.4%) |
| Mar 2020 | - | $12.68 M(-25.4%) |
| Dec 2019 | $16.99 M(-18.2%) | $16.99 M(-17.5%) |
| Sept 2019 | - | $20.60 M(-14.8%) |
| June 2019 | - | $24.18 M(-16.3%) |
| Mar 2019 | - | $28.89 M(+39.1%) |
| Dec 2018 | $20.77 M(+229.9%) | $20.77 M(+49.2%) |
| Sept 2018 | - | $13.92 M(+282.3%) |
| June 2018 | - | $3.64 M(-15.4%) |
| Mar 2018 | - | $4.30 M(-31.7%) |
| Dec 2017 | $6.29 M(+118.7%) | $6.29 M(+86.3%) |
| Sept 2017 | - | $3.38 M(-1.8%) |
| June 2017 | - | $3.44 M(+208.4%) |
| Mar 2017 | - | $1.12 M(-61.2%) |
| Dec 2016 | $2.88 M(-37.3%) | $2.88 M(-34.3%) |
| Sept 2016 | - | $4.38 M(-14.7%) |
| June 2016 | - | $5.13 M(+86.6%) |
| Mar 2016 | - | $2.75 M(-40.1%) |
| Dec 2015 | $4.59 M(-55.1%) | $4.59 M(+241.5%) |
| Sept 2015 | - | $1.34 M(-54.0%) |
| June 2015 | - | $2.92 M(-67.5%) |
| Mar 2015 | - | $8.99 M(-12.1%) |
| Dec 2014 | $10.23 M(-35.3%) | $10.23 M(-11.4%) |
| Sept 2014 | - | $11.54 M(-7.9%) |
| June 2014 | - | $12.53 M(-11.6%) |
| Mar 2014 | - | $14.16 M(-10.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2013 | $15.81 M(+72.9%) | $15.81 M(+265.7%) |
| Sept 2013 | - | $4.32 M(-23.3%) |
| June 2013 | - | $5.63 M(-25.7%) |
| Mar 2013 | - | $7.59 M(-17.1%) |
| Dec 2012 | $9.15 M(-209.8%) | $9.15 M(-14.8%) |
| Sept 2012 | - | $10.74 M(+2065.4%) |
| June 2012 | - | $495.90 K(+50.0%) |
| Mar 2012 | - | $330.50 K(-104.0%) |
| Dec 2011 | -$8.33 M(+6431.8%) | -$8.33 M(+23.4%) |
| Sept 2011 | - | -$6.75 M(+902.0%) |
| June 2011 | - | -$673.50 K(+23.0%) |
| Mar 2011 | - | -$547.50 K(+329.4%) |
| Dec 2010 | -$127.50 K(-105.0%) | -$127.50 K(+147.1%) |
| Sept 2010 | - | -$51.60 K(-63.2%) |
| June 2010 | - | -$140.20 K(-109.2%) |
| Mar 2010 | - | $1.52 M(-40.6%) |
| Dec 2009 | $2.56 M(-612.1%) | $2.56 M(<-9900.0%) |
| Sept 2009 | - | -$10.30 K(-97.8%) |
| June 2009 | - | -$462.30 K(-80.8%) |
| Mar 2009 | - | -$2.41 M(+380.5%) |
| Dec 2008 | -$500.70 K(-292.2%) | -$500.70 K(-120.8%) |
| Sept 2008 | - | $2.41 M(-30.8%) |
| June 2008 | - | $3.48 M(+105.5%) |
| Mar 2008 | - | $1.70 M(+551.0%) |
| Dec 2007 | $260.50 K(-42.6%) | $260.50 K(-69.7%) |
| Sept 2007 | - | $859.00 K(>+9900.0%) |
| June 2007 | - | $1700.00(-99.6%) |
| Mar 2007 | - | $468.70 K(+3.3%) |
| Dec 2006 | $453.60 K(-32.8%) | $453.60 K(+74.9%) |
| Sept 2006 | - | $259.40 K(-57.9%) |
| June 2006 | - | $615.50 K(+19.9%) |
| Mar 2006 | - | $513.30 K(-24.0%) |
| Dec 2005 | $675.00 K(-79.8%) | $675.00 K(+204.1%) |
| Sept 2005 | - | $222.00 K(-84.4%) |
| June 2005 | - | $1.42 M(-32.9%) |
| Mar 2005 | - | $2.12 M(-36.6%) |
| Dec 2004 | $3.35 M(-1.5%) | $3.35 M(-19.9%) |
| Sept 2004 | - | $4.17 M(-17.9%) |
| June 2004 | - | $5.08 M(-12.8%) |
| Mar 2004 | - | $5.83 M(+71.6%) |
| Dec 2003 | $3.40 M | $3.40 M(+119.6%) |
| Sept 2003 | - | $1.55 M(-2.0%) |
| June 2003 | - | $1.58 M |
FAQ
- What is Oragenics annual working capital?
- What is the all time high annual working capital for Oragenics?
- What is Oragenics quarterly working capital?
- What is the all time high quarterly working capital for Oragenics?
- What is Oragenics quarterly working capital year-on-year change?
What is Oragenics annual working capital?
The current annual working capital of OGEN is $2.07 M
What is the all time high annual working capital for Oragenics?
Oragenics all-time high annual working capital is $26.26 M
What is Oragenics quarterly working capital?
The current quarterly working capital of OGEN is $1.99 M
What is the all time high quarterly working capital for Oragenics?
Oragenics all-time high quarterly working capital is $35.85 M
What is Oragenics quarterly working capital year-on-year change?
Over the past year, OGEN quarterly working capital has changed by -$80.80 K (-3.91%)